e-Drug3D

812

RISEDRONATE


INN
RISEDRONATE

cas 105462-24-6
CLASS

MUSCULO-SKELETAL
OSTEOPOROSIS
OSTEOCLASTIC RESORPTION INHIBITOR
BISPHOSPHONATES
HAS AN AFFINITY FOR HYDROXYAPATITE CRYSTALS IN BONE AND ACTS AS AN ANTIRESORPTIVE AGENT

ROUTE (list)

ORAL

ATC code

M05BA07
M05BB02
M05BB07
M05BB04

PK parameters

F 0.63 PERCENT
Tmax 1 HOUR
VD 897 LITER (65 KILOGRAM)
Cl 7.3 LITER / HOUR
PPB 24 PERCENT
t1/2 561 HOUR

Solubility

SOLUBLE IN WATER


Target

TARGET FARNESYL PYROPHOSPHATE SYNTHASE

PDB
4KPD (CRYSTAL STRUCTURE OF HUMAN FARNESYL PYROPHOSPHATE SYNTHASE (Y204F) MUTANT COMPLEXED WITH MG, RISEDRONATE AND ISOPENTENYL PYROPHOSPHATE)

Ligand code = RIS (link to the list of PDB complexes)

Download experimental 3D coordinates of RIS with added hydrogens

DrugCentral

Farnesyl pyrophosphate synthase UNIPROT P14324 FDPS

Download SDF file (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid

Formula:
C7H11NO7P2

Calculated chemical properties:

MW 279.08
NB_atoms 17
XLogP -2.90
PSA 140.254
NB_HD 1
NB_HA 8
fsp3 0.29
Lipinski(0=no;1=yes) 0

FDA
NDA 020835 (label) INN (RISEDRONATE SODIUM) ACTONEL (APIL) APPROVAL= AP YEAR= 1998
NDA 021823 (label) INN (CALCIUM CARBONATE ; RISEDRONATE SODIUM) ACTONEL WITH CALCIUM COPACKAGED (WARNER CHILCOTT) APPROVAL= AP YEAR= 2005 DISCONTINUED
NDA 077132 (label) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (TEVA PHARMS USA) APPROVAL= AP YEAR= 2007
NDA 022560 (label) INN (RISEDRONATE SODIUM) ATELVIA (APIL) APPROVAL= AP YEAR= 2010
NDA 079215 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (TEVA PHARMS USA) APPROVAL= AP YEAR= 2014
NDA 200477 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (PHARMOBEDIENT) APPROVAL= AP YEAR= 2014 DISCONTINUED
NDA 090877 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (APOTEX) APPROVAL= AP YEAR= 2014
NDA 090886 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (SUN PHARM) APPROVAL= AP YEAR= 2014
NDA 200296 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2015
NDA 203217 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (TEVA PHARMS USA) APPROVAL= AP YEAR= 2015
NDA 203533 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2015
NDA 206768 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2016
NDA 203822 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (ZYDUS PHARMS) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 205066 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (IMPAX LABS INC) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 205280 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (ORBION PHARMS) APPROVAL= AP YEAR= 2019
NDA 207516 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (HANGZHOU BINJIANG) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 203925 (pdf not found) INN (RISEDRONATE SODIUM) RISEDRONATE SODIUM (SUN PHARM) APPROVAL= AP YEAR= 2019 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL